Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;114(5):481-492.
doi: 10.1007/s00347-017-0494-y.

[Fuchs uveitis]

[Article in German]
L Daas  1 , B Seitz  2 , U Pleyer  3
Affiliations
Review

[Fuchs uveitis]

[Article in German]
L Daas et al. Ophthalmologe. 2017 May.

Abstract

Fuchs uveitis (FU) is a frequent, chronic course of intraocular inflammation, which is associated with a gradual onset of decreased visual acuity. The clinical manifestation of the triad of heterochromia, cataract and glaucoma varies considerably. This explains the often delayed diagnosis. Although the aetiology and pathogenesis of the changes are still unclear, there is no doubt that infections play a significant role. Intraocular antibodies directed against rubella viruses show a high association with the disease pattern, and their detection can even be used to support the diagnosis. The treatment of FU is limited to symptomatic measures. Corticosteroids are usually only moderately effective and should be used with caution due to adverse effects, with progression of cataract and secondary glaucoma. The prognosis of the disease can be regarded as favourable and depends essentially on the secondary changes.

Keywords: Anterior uveitis; Cytomegalovirus; Heterochromia; Inflammation; Rubella virus.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Acta Ophthalmol Scand. 1995 Apr;73(2):166-70 - PubMed
    1. Klin Monbl Augenheilkd. 2010 May;227(5):407-12 - PubMed
    1. Br J Ophthalmol. 1992 Jan;76(1):22-4 - PubMed
    1. Am J Ophthalmol. 2002 Oct;134(4):481-98 - PubMed
    1. Int Ophthalmol. 2010 Oct;30(5):521-9 - PubMed

Substances

LinkOut - more resources